LG AI Research· EXAONEPartnership

LG AI Research and D&D Pharmatech Partner to Advance AI-Powered Next-Generation Peptide Drug Discovery

LG AI Research and D&D Pharmatech have signed a definitive agreement to jointly develop next-generation peptide therapeutics, combining AI-driven drug discovery with oral delivery technologies.

From the source

LG AI Research signed a definitive agreement with D&D Pharmatech on June 16 at the LG Twin Towers in Yeouido, Seoul, to jointly develop next-generation peptide therapeutics.

lgresearch.ai

Announced

17 Jun 2026 00:00 UTC

Detected

28 Aug 2026 22:20 UTC (+72d after)